Related Experiment Video
Updated: Nov 27, 2025

Author Spotlight: Integrating BRET-Based Assays and Rare Mutation Analysis to Decipher RAF Kinase Regulation in Live Cells
Published on: March 1, 2024
BRAF: A Two-Faced Janus
Pasquale Pisapia1, Francesco Pepe1, Antonino Iaccarino1
1Department of Public Health, University of Naples Federico II, 80131 Naples, Italy.
Abstract:
Gain-of-function of V-Raf Murine Sarcoma Viral Oncogene Homolog B (BRAF) is one of the most frequent oncogenic mutations in numerous cancers, including thyroid papillary carcinoma, melanoma, colon, and lung carcinomas, and to a lesser extent, ovarian and glioblastoma multiforme. This mutation aberrantly activates the mitogen-activated protein (MAP) kinase extracellular signal-regulated kinase (MEK)/extracellular signal-regulated kinase (ERK) signaling pathway, thereby eliciting metastatic processes. The relevance of BRAF mutations stems from its prognostic value and, equally important, from its relevant therapeutic utility as an actionable target for personalized treatment. Here, we discuss the double facets of BRAF. In particular, we argue the need to implement diagnostic molecular algorithms that are able to detect this biomarker in order to streamline and refine diagnostic and therapeutic decisions.
Insights
Gain-of-function mutations in V-Raf Murine Sarcoma Viral Oncogene Homolog B (BRAF) drive cancer metastasis by activating the MEK/ERK pathway. Detecting BRAF mutations is crucial for personalized cancer treatment and improved patient outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Gain-of-function mutations in V-Raf Murine Sarcoma Viral Oncogene Homolog B (BRAF) are prevalent in various cancers, including thyroid, melanoma, colon, and lung carcinomas.
- These BRAF mutations aberrantly activate the mitogen-activated protein (MAP) kinase pathway, specifically the MEK/ERK signaling cascade, promoting cancer cell metastasis.
Purpose of the Study:
- To discuss the dual role of BRAF mutations in cancer development and as a therapeutic target.
- To emphasize the importance of diagnostic molecular algorithms for BRAF mutation detection.
Main Methods:
- Literature review and analysis of BRAF mutation roles in cancer.
- Discussion on the clinical implications of BRAF as a prognostic and predictive biomarker.
Main Results:
- BRAF mutations are key drivers in multiple cancer types, influencing prognosis.
- BRAF serves as an actionable target for personalized cancer therapies.
Conclusions:
- Implementing diagnostic molecular algorithms to detect BRAF mutations is essential.
- Accurate BRAF detection streamlines diagnostic and therapeutic decision-making for improved patient care.
More Related Videos
07:49Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
07:26Isolation of Whole Cell Protein Lysates from Mouse Facial Processes and Cultured Palatal Mesenchyme Cells for Phosphoprotein Analysis
Published on: April 1, 2022
Related Concept Videos
Mechanical Protein Function
Structural Protein Function
Structural Protein Function
Collagen, the most abundant protein in mammals, is found throughout the body. In connective tissue, such as skin, ligaments, and tendons, it provides tensile strength and elasticity. In bones and teeth, it mineralizes to...
Rab Proteins
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
Protein Complexes with Interchangeable Parts
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
Mechanical Protein Functions